Our Experts Are Your Experts
Expert Community offers insight and analysis on timely topics through articles, white papers and multimedia presentations from PPD’s biopharmaceutical industry thought leaders. Through this robust collection, PPD addresses the most pressing questions facing the clinical research industry.
Learn about PPD’s proven experience and expertise in diabetes and metabolic research.
Read a case study about a Phase I-III clinical development program to assess the efficacy and safety of a glucagon-like peptide-1 (GLP-1) in the treatment of Type 2 diabetes mellitus (T2DM).
Including hyperglycemic rescue criteria in type 2 diabetes clinical trials is vital. PPD’s white paper details how hyperglycemic rescue criteria in type 2 diabetes clinical trials support the best outcomes for trials and patients.